Sabin Vaccine Institute appoints new CEO

The Sabin Vaccine Institute has announced that Michael W. Marine, the former U.S. Ambassador to the Socialist Republic of Vietnam, has been appointed as the institute's new chief executive officer.

"I am honored to work with such a talented team and excited to build on Sabin's success," Marine said. "I've lived in many places where access to basic health resources is considered a privilege and survival is often a question. As CEO, it's my goal to ensure that Sabin contributes to efforts to further accelerate access to vaccines and treatments that prevent and cure infectious and neglected tropical diseases for those who need them."

Marine served with the U.S. State Department's Foreign Service for 32 years and was a six time recipients of the Department's Superior Honor Award.

"Michael Marine will be a tremendous asset to our team," Dr. Peter Hotez, Sabin's president, said. "Sabin and our programs have achieved unprecedented success and grown rapidly in recent years. Michael has the experience and commitment to sustain that growth while ensuring that we continue to invest in our infrastructure and our mission."

Marine joined the leadership team at Sabin in December 2009 following eight months of service on the Joint Action Committee of the Global Network for Neglected Tropical Diseases.

He is a 1974 graduate, summa cum laude, from the University of California at Santa Barbara.

"Michael Marine's appointment to CEO was unanimously approved by the board," said Mort Hyman, chairman of the board of trustees at Sabin, said. "His many years of diplomatic experience in countries struggling with difficult health care challenges, particularly Africa and Asia, provides him a unique perspective that will be of tremendous value to Sabin and will add significant strength to our team."